Allergo-Derm Bakos Kft.
- Address
- lock Available on a paid plan
Allergo-Derm Bakos Kft. - Dermatology Clinical Research Center
Allergo-Derm Bakos Kft. is a specialized dermatology research center with extensive expertise in conducting clinical trials for inflammatory skin conditions. The center focuses on evaluating novel therapeutic interventions for chronic inflammatory dermatoses, with particular emphasis on immune-mediated skin diseases affecting quality of life in both adolescent and adult populations.
- Moderate to severe plaque psoriasis, including special area involvement and various body surface area presentations
- Moderate to severe atopic dermatitis (eczema) in adolescent and adult patients
- Novel biologic therapies and small-molecule inhibitors for dermatological conditions
- Combination therapy approaches utilizing topical corticosteroids and systemic agents
The research center demonstrates comprehensive capabilities in Phase 3 clinical trials, evaluating both monotherapy and combination treatment regimens. Their experience spans multiple therapeutic modalities including JAK inhibitors, monoclonal antibodies, and investigational biologics, with a focus on long-term safety monitoring and efficacy assessment using standardized dermatological outcome measures such as EASI and vIGA-AD scores.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Janssen Cilag International2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International5trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Allergo-Derm Bakos Kft.
lock Showing 1 of 23 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo- controlled, Parallel-group, Dose-ranging Study to Evaluate the Efficacy and Safety of DC-806 in Participants with Moderate to Severe Plaque Psoriasis | Dice Therapeutics Inc. | Phase II | Not Recruiting | Aug 2023 | Mar 2024 |
IMP list
lock Showing 1 of 21 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Jnj-77242113 | 5 | Unknown | 2023-12-05 | 2025-05-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.